n,n-dimethylarginine has been researched along with Injury, Myocardial Reperfusion in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Černe, D; Drevenšek, G; France Štiglic, A; Janić, M; Jerin, A; Lunder, M; Marc, J; Šabovič, M; Skitek, M | 1 |
| Burma, O; Ilhan, N; Ozguler, IM; Sahna, E; Uysal, A | 1 |
| Cerne, D; Drevensek, G; Janic, M; Jerin, A; Lunder, M; Marc, J; Sabovic, M; Skitek, M | 1 |
| Deng, HW; Jiang, JL; Li, YJ; Lu, R; Zhang, XH; Zhu, HQ | 1 |
| Berti, F; Berti, M; Bianchi, M; Bonomo, S; De Gennaro Colonna, V; Ferrario, P; Guazzi, M; Manfredi, B; Muller, EE; Rossoni, G | 1 |
| Conci, E; Cooke, JP; Haubner, BJ; Metzler, B; Pachinger, O; Schwaighofer, J; Stocker, EM; Stühlinger, MC; Tsao, PS | 1 |
6 other study(ies) available for n,n-dimethylarginine and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
Sub-therapeutic doses of fluvastatin and valsartan are more effective than therapeutic doses in providing beneficial cardiovascular pleiotropic effects in rats: A proof of concept study.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Aorta, Thoracic; Arginine; Blood Pressure; Cholesterol; Coronary Circulation; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Female; Fluvastatin; Heart; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Indoles; Male; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Nitric Oxide Synthase Type III; Rats, Wistar; Receptor, Endothelin A; Time Factors; Valsartan; Vasodilation | 2017 |
Effects of apocynin, an NADPH oxidase inhibitor, on levels of ADMA, MPO, iNOS and TLR4 induced by myocardial ischemia reperfusion.
Topics: Acetophenones; Animals; Arginine; Male; Myocardial Reperfusion Injury; Myocardium; NADPH Oxidases; Nitric Oxide Synthase Type II; Peroxidase; Rats; Rats, Sprague-Dawley; Toll-Like Receptor 4 | 2015 |
The "Rise-Peak-Fall" Pattern of Time Dependency of the Cardiovascular Pleiotropic Effects of Treatment With Low-dose Atorvastatin, Losartan, and a Combination Thereof in Rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Aorta, Thoracic; Arginine; Atorvastatin; Cardiovascular System; Carrier Proteins; CD40 Antigens; Coronary Circulation; Disease Models, Animal; Drug Therapy, Combination; Endothelium, Vascular; Female; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Isolated Heart Preparation; Losartan; Male; Myocardial Reperfusion Injury; Myocardium; Nitric Oxide; Nitric Oxide Synthase Type III; Rats, Wistar; Time Factors; Vasodilation | 2016 |
The protective effects of monophosphoryl lipid A on the ischemic myocardium and endothelium in rats.
Topics: Animals; Arginine; Cholesterol, LDL; Creatine Kinase; Endothelium, Vascular; Heart; Lipid A; Male; Myocardial Reperfusion Injury; Rats; Rats, Sprague-Dawley; Vasodilation | 2003 |
Asymmetric dimethylarginine (ADMA) induces vascular endothelium impairment and aggravates post-ischemic ventricular dysfunction in rats.
Topics: Acetylcholine; Angiotensin II; Animals; Aorta; Arginine; Blood Pressure; Endothelium, Vascular; Enzyme Inhibitors; Heart Rate; Male; Myocardial Reperfusion Injury; Nitrates; Nitrites; Perfusion; Rats; Rats, Wistar; RNA, Messenger; Vasoconstrictor Agents; Vasodilator Agents; Ventricular Dysfunction | 2007 |
Asymmetric dimethyl L-arginine (ADMA) is a critical regulator of myocardial reperfusion injury.
Topics: Amidohydrolases; Animals; Arginine; Blotting, Western; Endothelium, Vascular; Immunohistochemistry; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myocardial Ischemia; Myocardial Reperfusion Injury; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Peroxidase | 2007 |